Increased proportion of CD4+CD25+Foxp3+ regulatory T cells during early-stage sepsis in ICU patients

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 5, 2013, Pages 338-344

  Leng, Feng Ying ^a   Liu, Jia Lin ^a   Liu, Zhao Jun ^a   Yin, Jian Yong ^a   Qu, Hong Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD4+CD25+Foxp3+ regulatory T cell; Early stage sepsis; ICU; IFN IL 4; Sepsis; SIRS; Soluble CD25 molecules

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+CD25+FOXP3+ REGULATORY T LYMPHOCYTE; CONTROLLED STUDY; EARLY STAGE SEPTIC SHOCK; FEMALE; HUMAN; HUMAN CELL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CD4(+)CD25(+)FOXP3(+) REGULATORY T CELL; EARLY-STAGE SEPSIS; ICU; IFN-Γ/IL-4; SEPSIS; SIRS; SOLUBLE CD25 MOLECULES;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; EARLY DIAGNOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; SEPSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84885171783     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.06.012     Document Type: Article

References (17)

1. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.
2. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. New Engl J Med 2003, 348:138-150.
3. Hotchkiss R.S., Coopersmith C.M., McDunn J.E., Ferguson T.A. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009, 15:496-497.
4. Frazier W.J., Hall M.W. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 2008, 55:647-668. xi.
5. Boomer J.S., To K., Chang K.C., Takasu O., Osborne D.F., Walton A.H., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605.
6. Venet F., Chung C.S., Monneret G., Huang X., Horner B., Garber M., et al. Regulatory T cell populations in sepsis and trauma. JLeukoc Biol 2008, 83:523-535.
7. Chatila T.A. Role of regulatory T cells in human diseases. JAllergy Clin Immunol 2005, 116:949-959.
8. + regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003, 31:2068-2071.
9. Muckart D.J., Bhagwanjee S. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997, 25:1789-1795.
10. + T regulatory cells and HLA-DR expressing monocytes in severe intra-abdominal infections. Scand J Infect Dis 2010, 42:475-478.
11. + T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006, 244:514-523.
12. +CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care 2010, 14:R19.
13. Cook D.N., Hollingsworth J.W., Schwartz D.A. Toll-like receptors and the genetics of innate immunity. Curr Opin Allergy Clin Immunol 2003, 3:523-529.
14. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003, 197:403-411.
15. + regulatory T cells does not inhibit the action of IL-2. Scand J Immunol 2009, 70:40-43.
16. + T cells invitro. Int Immunopharmacol 2009, 9:340-346.
17. + regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med 2008, 216:61-68.